Previous 10 | Next 10 |
GlobeNewswire news releases related Globenewswire news releases and Globenewswire press releases from 01/24/20 04:05:10 on US and Canada Markets.
BEDFORD, Mass., Jan. 24, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform , today announced it h...
DUNMORE, Pa., Jan. 24, 2020 (GLOBE NEWSWIRE) -- FNCB Bancorp, Inc. (NASDAQ: FNCB), the parent company of Dunmore-based FNCB Bank (the “Bank”), today reported net income for 2019 of $11.1 million, or $0.56 per basic and diluted share, compared to net income of $13.3 million, or...
BROOKFIELD, Wis., Jan. 24, 2020 (GLOBE NEWSWIRE) -- CIB Marine Bancshares, Inc. (the “Company” or “CIBM”) (OTCQB: CIBH), the holding company of CIBM Bank, announced its unaudited results of operations and financial condition for the fourth quarter and year-end 20...
LAVAL, Quebec, Jan. 24, 2020 (GLOBE NEWSWIRE) -- WODEN VENTURE CAPITAL CORPORATION (WOD.H). (the “ Corporation ” or “ Woden ”) is pleased to announce the signing of a letter of intent dated January 22, 2020 with the shareholders of Geekco Technologies Inc. ( ...
TORONTO, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “company”) ( TSX, NYSE: HBM) senior management will host a conference call on Friday, February 21, 2020 at 9 a.m. ET to discuss the company’s fourth quarter 2019 results an...
THE WOODLANDS, Texas, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today real-world data on XERMELO’s ® (telotristat ethyl) antiproliferative effects in patients with carcinoid syndrome that were presented at the American Socie...
SBP-101 was well tolerated in combination with gemcitabine and nab-paclitaxel Objective Response Rate (ORR) was 62% by RECIST criteria Study expansion in patients with pancreatic cancer planned to begin in Q2 SAN FRANCISCO, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB...
JASPER, Ind., Jan. 24, 2020 (GLOBE NEWSWIRE) -- Kimball Electronics, Inc. (NASDAQ: KE) will announce its second quarter fiscal year 2020 financial results on Wednesday, February 5, 2020 after the closing of the market. The company will hold a conference call and live webcast to review th...
NEW YORK, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Brookfield Public Securities Group LLC (“Brookfield”) announced that, at the Joint Special Meeting of Stockholders (the “Special Meeting”) held earlier today, stockholders of Brookfield Real Assets Income Fund Inc. (NYS...
NEW YORK, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Brookfield Public Securities Group LLC (“Brookfield”) announced that, at the Joint Special Meeting of Stockholders (the “Special Meeting”) held earlier today, stockholders of Brookfield Real Assets Income Fund Inc. (NYS...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
18.68%Change Percent:
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
aptevotherapeutics.com Website: